Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Eby

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Journal of Thrombosis and Haemostasis : JTH|September 13, 2024
Estimation of gestational age-specific reference intervals for coagulation assays in a neonatal intensive care unit using real-world dataNatasha Lalos, Zachary Vesoulis, Carly Maucione, et al.
Clinical Chemistry|August 15, 2009
Interactive modeling for ongoing utility of pharmacogenetic diagnostic testing: application for warfarin therapyMark W Linder, Marjorie Bon Homme, Kristen K Reynolds, et al.
Research and Practice in Thrombosis and Haemostasis|May 8, 2025
Comparison of 2 thromboelastography methods using patient and control samplesRobert Frick, Brittany Washburn, Dennis Plocher, et al.
Operative Neurosurgery (Hagerstown, Md.)|May 26, 2018
Plasmapheresis for Management of Antiphospholipid Syndrome in the Neurosurgical PatientEric J Arias, Brent Bruck, Ananth K Vellimana, et al.
American Journal of Preventive Medicine|December 29, 2009
Improving influenza vaccination rates in the workplace: a randomized trialMary Patricia Nowalk, Chyongchiou J Lin, Seth L Toback, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 13, 2010
Heparin and oversulfated heparin byproduct induce thrombin generation through contact system activation in plasma of patients with HITYi Qian, Jing Pan, Xiaodong Zhou, et al.
American Journal of Clinical Pathology|May 16, 2008
Performance of commercial platforms for rapid genotyping of polymorphisms affecting warfarin doseCristi R King, Rhonda M Porche-Sorbet, Brian F Gage, et al.
Thrombosis and Haemostasis|August 10, 2010
Gamma-glutamyl carboxylase and its influence on warfarin doseCristi R King, Elena Deych, Paul Milligan, et al.
Thrombosis Research|July 29, 2011
The occurrence of antibodies to heparin-platelet factor 4 in cardiac and thoracic surgical patients receiving desirudin or heparin for postoperative venous thrombosis prophylaxisMichael S Avidan, Jennifer R Smith, Lee P Skrupky, et al.
Thrombosis and Haemostasis|April 21, 2005
Prospective dosing of warfarin based on cytochrome P-450 2C9 genotypeDeepak Voora, Charles Eby, Mark W Linder, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of Thrombosis and Haemostasis : JTH|September 13, 2024
Estimation of gestational age-specific reference intervals for coagulation assays in a neonatal intensive care unit using real-world dataNatasha Lalos, Zachary Vesoulis, Carly Maucione, et al.
Clinical Chemistry|August 15, 2009
Interactive modeling for ongoing utility of pharmacogenetic diagnostic testing: application for warfarin therapyMark W Linder, Marjorie Bon Homme, Kristen K Reynolds, et al.
Research and Practice in Thrombosis and Haemostasis|May 8, 2025
Comparison of 2 thromboelastography methods using patient and control samplesRobert Frick, Brittany Washburn, Dennis Plocher, et al.
Operative Neurosurgery (Hagerstown, Md.)|May 26, 2018
Plasmapheresis for Management of Antiphospholipid Syndrome in the Neurosurgical PatientEric J Arias, Brent Bruck, Ananth K Vellimana, et al.
American Journal of Preventive Medicine|December 29, 2009
Improving influenza vaccination rates in the workplace: a randomized trialMary Patricia Nowalk, Chyongchiou J Lin, Seth L Toback, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 13, 2010
Heparin and oversulfated heparin byproduct induce thrombin generation through contact system activation in plasma of patients with HITYi Qian, Jing Pan, Xiaodong Zhou, et al.
American Journal of Clinical Pathology|May 16, 2008
Performance of commercial platforms for rapid genotyping of polymorphisms affecting warfarin doseCristi R King, Rhonda M Porche-Sorbet, Brian F Gage, et al.
Thrombosis and Haemostasis|August 10, 2010
Gamma-glutamyl carboxylase and its influence on warfarin doseCristi R King, Elena Deych, Paul Milligan, et al.
Thrombosis Research|July 29, 2011
The occurrence of antibodies to heparin-platelet factor 4 in cardiac and thoracic surgical patients receiving desirudin or heparin for postoperative venous thrombosis prophylaxisMichael S Avidan, Jennifer R Smith, Lee P Skrupky, et al.
Thrombosis and Haemostasis|April 21, 2005
Prospective dosing of warfarin based on cytochrome P-450 2C9 genotypeDeepak Voora, Charles Eby, Mark W Linder, et al.
Pageof 3